CXCL13 and idiopathic pulmonary fibrosis: It is of note that in IPF patients, increased plasma concentrations of BAFF (or BLyS) correlated with clinical severity and negative outcomes of these patients43 and longitudinal increment of plasma levels of CXCL13 and high lung expression of CXCL13 have been associated with severe clinical manifestations and disease progression.44